BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2013
View Archived Issues
Novel candidate JNK1 inhibitors patented
Read More
U.S. group prepares new HCV treatments
Read More
Novo Nordisk releases financial statement for 2012
Read More
Dainippon Sumitomo Pharma updates activities of third quarter of fiscal 2012
Read More
Huntington's disease model extensively characterized
Read More
Study results inform phase III trial design for enterovirus 71 vaccine
Read More
Novel inhibitors of Janus kinases developed at Roche
Read More
Enkephalin analgesics divulged by Pfizer
Read More
Phenex Pharmaceuticals reported new FXR modulators
Read More
Gilead Sciences reports topline results from phase III sofosbuvir studies
Read More
Kymab launches program to develop monoclonal antibody therapeutics
Read More
StemEx product shows efficacy in phase II/III hematological malignancy study
Read More
First patient receives treatment in phase IIa NurOwn stem cell therapy trial
Read More
Pooled data study finds cardiovascular safety similar between peginesatide and comparators
Read More
Japanese government provides funding for unoprostone isopropyl development
Read More
Glenmark Pharmaceuticals discovers novel monoclonal antibody targeting OX40
Read More
The Medicines Company and Alnylam to develop therapeutics for hypercholesterolemia
Read More
Rockwell Medical's PRIME study meets primary endpoint
Read More
Biotest launches Bivigam for primary humoral immunodeficiency
Read More
NAD kinase inhibition has oncolytic potential
Read More
European approval for Zaltrap in metastatic colorectal cancer
Read More
FDA issues complete response letter for Ampligen in chronic fatigue syndrome
Read More
Medigene expands clinical development plan for RhuDex
Read More
Preclinical findings show promise of hpSC-derived neuronal cells for Parkinson's disease
Read More
Idenix discontinues IDX-184 and IDX-19368 HCV programs
Read More
